Upload
chaela
View
29
Download
1
Tags:
Embed Size (px)
DESCRIPTION
A Knowledge Based Economy (KBE) * Money, Time and Talent !. Building. History | KBE | Biomed | S&E | Talent | Enterprise. Map of Singapore: Location of one-north. Nanyang Technological University. Changi Airport. one-north. Biopolis. National University of S’pore - PowerPoint PPT Presentation
Citation preview
AKnowledge Based Economy
(KBE)
* Money, Time and Talent !
History | KBE | Biomed | S&E | Talent | Enterprise
Building
Map of Singapore: Location of one-north
ChangiAirportChangiAirport
National University of S’poreNational University HospitalNational University of S’poreNational University HospitalTuas
Biomedical ParkTuasBiomedical Park City CentreCity Centre
Seaport & Container Terminals
Seaport & Container Terminals
one-northone-north
SGHSGH
Nanyang Technological UniversityNanyang Technological University
Jurong IslandJurong Island
BiopolisBiopolisFusionopolisFusionopolis
Labour-intensive
Skills-intensive
Capital-intensive
Technology-intensive
Innovator of new products
& services
Knowledge-Intensive
Singapore’s Economic Progress
Keep moving up !
History | KBE | Biomed | S&E | Talent | Enterprise
History | KBE | Biomed | S&E | Talent | Enterprise
0
5,000
10,000
15,000
20,000
25,000
1965 1970 1975 1980 1985 1990
The Turning Point
1985: Economy shrank 1.5%1985: 4% unemployment1986: 7% unemployment
1985/6Recession
1987Recovery
Independence1965
S$ 1,567(1965)
S$14,345(1986)
GD
P P
er c
apit
a (S
$)
The UpTurn
History | KBE | Biomed | S&E | Talent | Enterprise
GD
P P
er c
apit
a (S
$)
1986: Economy grew 2%1987: Economy grew 9%1988: 20,000 new jobs created
S$14,345(1986)S$ 1,567
(1965)
Independence1965
S$46,832(2006)
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
45,000
50,000
1965 1970 1975 1980 1985 1990 1995 2000 2005
0
5,000
10,000
15,000
20,000
25,000
1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006
S$ Mil
Building the Data Storage Industry ClusterCumulative Output (1986-2000): S$170 billion
S$11 billion(2006)
S$20 billion(1997)
S$2.4 billion(1986)
Building the Semiconductor Industry Cluster
S$36 billion(2006)
Cumulative Output (1986-2000): S$122 billion
S$11 billion(1998)
S$2.3 billion(1986)
0
10,000
20,000
30,000
40,0001
98
0
19
82
19
84
19
86
19
88
19
90
19
92
19
94
19
96
19
98
20
00
20
02
20
04
20
06
Building The Chemicals Industry Cluster
10,000
20,000
30,000
40,000
50,000
60,000
1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006
S$ Million
Cumulative Output (1986 – 2000) - S$266 billionS$76 billion
(2006)
Off
icia
l O
pe
nin
g
of
Ju
ron
g I
slan
d
199
5 C
on
stru
ctio
nst
arte
d o
n J
uro
ng
Isl
and
History | KBE | Biomed | S&E | Talent | Enterprise(S
$32
bil
lio
n)
(S$1
7 b
illi
on
)
The Jurong Island Story
These seven tiny islands (800 ha in all) then became …..
… a 3,400 ha single island
1991 present
History | KBE | Biomed | S&E | Talent | Enterprise
Jurong Island TodayJurong Chemical Island ….Today
… a 3,400 ha single island
2006 GDP Pie (S$210 billion)
27.7%(Manufacturing)
3.6%(Construction)
15.2%(Wholesale &Retail Trade)9.6%
(Transport &Storage)
1.9%(Hotels &
Restaurants)
3.8%(Info & Comms)
11.2%(Financial Svcs)
11.5%(Business Svcs)
10.2%(Other Services)
5.2%(Others)
Manufacturing
Construction
Wholesale & Retail Trade
Transport & Storage
Hotels and Restaurants
Information & Communications
Financial Services
Business Services
Other Services
Others
History | KBE | Biomed | S&E | Talent | Enterprise
MANUFACTURING
Manufacturing
S$ Million
Biomedical Sciences
Electronics
Chemicals
0
20,000
40,000
60,000
80,000
100,000
1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006p
Electronics (incl Data Storage and Semiconductors) Chemicals BMS Precision Engrg
Precision Engrg
History | KBE | Biomed | S&E | Talent | Enterprise
Total Manufacturing Output of 4 key clusters : $235 billion (2006)
Manufacturing
0
1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006p
Electronics Chemicals BMS Precision Engrg
20000
40000
60000
80000
100000
120000
140000
Person
Electronics
PrecisionEngrg
Chemicals
BiomedicalSciences
History | KBE | Biomed | S&E | Talent | Enterprise
Total Employment in 4 clusters : 223, 277 (2006)
Singapore has promoted and attracted 4 waves of investments: -
* Data storage (1986-1990)
* Semiconductors (1991-1995)
* Chemicals (1996 to 2000)
* Biomedical industries (2001 to 2006)
Creation of 4 clusters of growth
Four Industry Waves (1986 to 2006)
Data Storage S$170 b
Semiconductors S$122 b
Chemicals S$266 b
Biomedical Sciences S$125 b
History | KBE | Biomed | S&E | Talent | Enterprise
Stagnation
Labour Intensive
Skills Intensive
Capital Intensive
Technology Intensive
GD
P P
er c
apit
a (S
$)Where do we go from here?
High Growth
Decline
History | KBE | Biomed | S&E | Talent | Enterprise
1965 – 1978: Export Oriented Industrialisation
1986 – 2000:Capability Building and
Economic Diversification
Moving forward to a Knowledge Based Economy model
1979 – 1985: Industrial Restructuring
2001 onwards:Transforming to Knowledge-
Based Economy
History | KBE | Biomed | S&E | Talent | Enterprise
From Manufacturing to Knowledge-Based Economy
• An Economy based on cost efficiency is not sustainable in the long term
• Move up the Value chain with focus on high value-added activities
• Graduate Education is a necessity for high value-added R&D-oriented industries
• Research Development Production Marketing Distribution Servicing
History | KBE | Biomed | S&E | Talent | Enterprise
What is a Knowledge-Based Economy?
How do we create knowledge and useful ideas? R&D and innovation.
Where? New high growth areas like biomedical sciences, nanotechnology, energy.
Why? R&D generates intellectual property (IP) and this is the “real value-added” R&D complements our manufacturing core. Coupling the two will create clusters of high value-added activity.
Create, Own + Exploit (COE) Knowledge
History | KBE | Biomed | S&E | Talent | Enterprise
Science and Engineering
Research Council
Biomedical Research Council
Exploit Technologies
Corporate Planning and
Administration
A*STAR Graduate Academy
Building up the R&D foundation (2001)
History | KBE | Biomed | S&E | Talent | Enterprise
A*STAR’s Foundations
Researchgovernance framework
Research Infrastructure
Talent- DevelopmentCommercialisation
InternationalPartnerships
Research governance framework
* Established Research Councils and RI Scientific Advisory Boards
Research Infrastructure
* Completed Biopolis Phase 1 & Phase 2
Focus on Talent
* Attracted international scientific leaders and scientists
* Set up A*STAR Graduate Academy to groom Singaporean PhD talent
Encourage Commercialisation
* Streamlined Intellectual Property policies* Established Commercialisation of Technology
Fund
International Partnerships
* Partnerships for research collaboration and graduate education/training
History | KBE | Biomed | S&E | Talent | Enterprise
A snapshot of Singapore’s current R&D scene
History | KBE | Biomed | S&E | Talent | Enterprise
International Comparison of R&D IntensityInternational Comparison of R&D Intensity
Source: National Survey of R&D in Singapore 2005 and OECD MSTI 2006_1
Finland
Ireland
Japan
Korea
Total OECDSingapore2.36% (2005)
United StatesTaiwan
1
1.5
2
2.5
3
3.5
4
2000 2001 2002 2003 2004 2005
Year
R&
D /
GD
P %
History | KBE | Biomed | S&E | Talent | Enterprise
Singapore’s Goal: 3.0% by 2010Singapore’s Goal: 3.0% by 2010Limit: TALENTLimit: TALENT
Singapore1.88%(2000)
Building up R&D Human Capital
2000 - 2006R
esea
rch
Sci
entis
ts a
nd E
ngin
eers
(R
SE
)
RS
E p
er 1
0,00
0
History | KBE | Biomed | S&E | Talent | Enterprise
10000
12000
14000
16000
18000
20000
22000
24000
26000
28000
2000 2001 2002 2003 2004 2005 2006
10
30
50
70
90
110
130
No. of research manpower
No. of research manpower per 10,000 labour force
No. of Patents Applied / Awarded
History | KBE | Biomed | S&E | Talent | Enterprise
0200400600800
1000120014001600180020002200
2000 2001 2002 2003 2004 2005 2006Patents applied
Patents awarded
Goal
Building up Biomedical Sciences
A*STAR2001
History | KBE | Biomed | S&E | Talent | Enterprise
Vision
Singapore – The Biopolis of AsiaSingapore – The Biopolis of Asia
Basic, Translational
& Clinical Research
Product & Process
Development
Pilot & Commercial
Manufacturing
Regional HQ & Shared Services
Healthcare Delivery
An International Biomedical Sciences Cluster Advancing Human Health
Through the Pursuit of Excellence in Research & Development, Manufacturing, and Healthcare Delivery
History | KBE | Biomed | S&E | Talent | Enterprise
S*BIOResearch Development Manufacturing Healthcare
Services
Human Capital Development
Intellectual Capital
Development
Industrial Capital Development
Biomedical Sciences Value Chain
History | KBE | Biomed | S&E | Talent | Enterprise
How It All Started….
A/Prof. Kong Hwai LoongProf. John Wong
Prof. Tan Chorh Chuan26thJune 2000
Sir Richard Sykes (Chairman)Imperial College (UK)
Dr John Mendelssohn (Co-Chairman)MD Anderson (USA)
Dr David Baltimore (Emeritus)California Institute of Technology(USA)
Dr Leland HartwellFred Hutchinson CancerResearch Center (USA)
Dr Colin BlakemoreMedical Research Council(UK)
Dr Richard Lerner (Emeritus)Scripps Research Institute(USA)
Dr John Reed (Emeritus)Burnham Institute(USA)
Dr John BellUniversity of Oxford(UK)
Dr Sydney BrennerThe Salk Institute(USA)
Sir George Radda (Emeritus)University of Oxford(UK)
Dr Harriet Wallberg-HenrikssonKarolinska Institutet(Sweden)
Dr Peter GrussMax Planck Society(Germany)
Dr Philippe Kourilsky (Emeritus)College de France(France)Dr Alan Bernstein (Emeritus)Canadian Institutes of Health Research (Canada)
Dr Suzanne CoryWEHI (Australia)
Dr Samuel Barondes (Emeritus)University of California, SanFrancisco (USA)
Dr David I. Hirsh (Emeritus)Columbia University(USA)
Dr Paul A. Marks (Emeritus)Memorial Sloan-Kettering CancerCenter (USA)
Dr Alan Munro (Emeritus)University of Cambridge(UK)
Sir Keith Peters (Emeritus)GlaxoSmithKline(UK)
Dr Hans Wigzell (Emeritus)Karolinska Institutet(Sweden)
Dr Axel Ullrich (Emeritus)Max-Planck Institute of Biochemistry (Germany)
Dr John Shine (Emeritus)Garvan Institute of Medical Research (Australia)
Dr Susan Lindquist (Emeritus)Whitehead Institute of Biomedical Research (USA)
Dr Stanley N. Cohen (Emeritus)Stanford University(USA)
Dr Helen HobbsUT Southwestern (USA)
Dr Tadataka YamadaGates Foundation (USA)
Dr Rolf ZinkernagelUniversity of Zurich (Switzerland)
Dr William EvansSt Jude (USA)
Sir Philip CohenUniversity of Dundee (UK)
Dr Anthony PawsonSamuel Lunenfeld Research Institute (Canada)
BMS International Advisory Council
Breaking New Ground in 2001 …Biopolis
History | KBE | Biomed | S&E | Talent | Enterprise
Biopolis
Biopolis Phase 1
All 5 BMRC Research Institutes S&T offices (British High Com and RIKEN) Corporate labs (NITD, GSK) 185,000 square metres Officially opened on October 2003
Biopolis Phase 2
BMRC Research Institutes Corporate labs Additional 37,000 square metres Officially opened on 30 October 2006
Biopolis 1
Biopolis 2
BMRC Research Institutes
Genome Institute of Singapore (GIS)
Institute of Bioengineering & Nanotechnology (IBN)
BioinformaticsInstitute (BII)
Institute of Medical Biology (IMB)
Singapore Institute for Clinical Sciences (SICS)
BioprocessingTechnologyInstitute (BTI)
Institute ofMolecular andCell Biology(IMCB)
History | KBE | Biomed | S&E | Talent | Enterprise
Phase 1 185,000 sqm S$500 million invested Public & corporate R&D labs > 95% of space committed
Phase 4
Phase 3
Shared Facilities Shared R&D equipment Shared animal facility
Phase 2 37,000 sqm Opened on 30 October 2006
Biopolis Tuas Biomedical Park
Tuas Biomedical Park I & II 360 Ha of prepared industrial land Ready infrastructure provided - Stable water, Electricity, Telecommunications, Sewerage discharge
Integrated Infrastructure: Tuas Biomedical Park
History | KBE | Biomed | S&E | Talent | Enterprise
Biomedical Sciences (BMS) Manufacturing Performance
1986-2006
History | KBE | Biomed | S&E | Talent | Enterprise
Out
put
$ ‘000S$23 billion
(2006)
0
5,000
10,000
15,000
20,000
25,00019
86
1988
1990
1992
1994
1996
1998
2000
2002
2004
2006
Manufacturing Output Value-Added
S$6 billion(2000)
Cumulative Output (1986 – 2006) - S$125 billion
0
2000
4000
6000
8000
10000
12000
1986
1988
1990
1992
1994
1996
1998
2000
2002
2004
2006
Biomedical Sciences (BMS) Actual Employment 1986 - 2006
5,880(2000)
10,572(2006)
Em
ploy
men
t
History | KBE | Biomed | S&E | Talent | Enterprise
Genomics & Proteomics
Bioprocessing
Chemical Synthesis
BIOTECHNOLOGYHEALTHCARESERVICES &
DELIVERY
Molecular & Cell Biology
Bioengineering &Nanotechnology
Computational Biology
Industry Sectors
Industry Sectors
Bioimaging
Cohort Studies
Biomarkers
Stem
cel
ls
Drug D
isco
very
CLINICAL RESEARCH
TRANSLATIONAL RESEARCH
PHARMACEUTICALS MEDICAL TECHNOLOGY
Biomedical Cluster Map
History | KBE | Biomed | S&E | Talent | Enterprise
MEaT = Medical Enginering and TechnologyIMCB = Institute of Molecular & Cell BiologyGIS = Genome Institute of SingaporeBTI = Bioprocessing Technical InstituteIBN = Institute of Bioengineering and NanotechnologyBII = Bioinformatics InstituteCMM = Centre for Molecular MedicineSICS = Singapore Institute for Clinical SciencesSBIC = Singapore Bioimaging Consortium
SIgN = Singapore Immunology NetworkSSCC = Singapore Stem Cell Consortium STN = Singapore Tissue NetworkSCS = Singapore Cancer SyndicateSCCS = Singapore Consortium of Cohort StudiesDPF = Data Privacy FrameworkBMS IF = Biomedical International FellowshipCSI = Clincian Scientist InvestigatorshipIRBs = Institutional Review Boards
Mission-oriented BENCH
INDUSTRY
Co-investment, VC funding
RISC grants, infrastructure, tax breaks
Pharma MEaT Biotech
Biologics (c
ells / v
accines)
Med tech
/ devic
es
Drug discove
ry & devt
Singapore Clinical Trials
• IMCB, GIS, BTI• IBN, BII, • CMM, SICS
Research Institutes
• SBIC• SSCC
• SIgN• Biomarkers
Research Consortia
Set up by A*STAR / BMRC
BEDSIDE
Clinical Research Programmes• Focus, strategy
Human Capital• Development, recruitment
Infrastructure• For Clinical Trials
Regulatory Framework• IRBs
DPF Office
MBBS PhD / BMS IF / CSI awards
Translational / Investigational
Medicine NMRC / HSA
Clinical Trials Overseas Clinical Trials
STN
SCS
SCCS
Academic BENCH
NUS, NTU
Clinical
BIOMEDICAL RESEARCH
TranslationalBasic
Singapore Health Services• Singapore General Hospital• National Cancer Centre• National Heart Centre• Singapore National Eye Centre• KK Women and Children’s Hospital• National Neuroscience Institute
National Healthcare Group• National University Hospital• The Cancer Institute• Tan Tock Seng Hospital• Communicable Disease Centre• National Skin Centre
Extramural Grants
− Singapore Cancer Syndicate− Singapore Bioimaging
Consortium − Singapore Stem Cell
Consortium− Singapore Immunology
Network− Member of Intl Cancer
Biomarker Consortium
Singapore Institute for Clinical Sciences (SICS)
• Develop programmes in Translational Clinical Medicine
• Develop critical resources:- Singapore Tissue Network- Singapore Consortium of Cohort Studies
• Develop Clinician Scientists:- Clinician Scientist Investigatorship (CSI) Awards- PhD training for medical doctors- Biomedical International Fellowships
MOH HQ- Ethical regulations/framework for
clinical research e.g. IRBs
NMRC- Clinical research strategy- Grant management- Manpower development
- HSA- Evaluation capabilities for new
technologies
Research Institutes
• Institute of Molecular & Cell Biology
• Genome Institute of Singapore
• Institute of Bioengineering & Nanotechnology
• Bioprocessing Technology Institute
• Bioinformatics Institute
UNIVERSITIES
Institute of Medicinal Biology (IMB)
CMM @ Biopolis(2006 -2008)− Singapore Oncogenome Group− Regenerative Medicine− Epithelial Biology
Consortia
SICS @ Kent Ridge- Genetic Medicine- Virology/Infectious Diseases
SICS @ Outram(2008-2010)− Cardiovascular Diseases− Eye Diseases
A*STAR Biomedical Research Ministry Of Health
Hub for Clinical Trials & Regional Management
14 emp Phase 1-4 Trials
10 emp Phase 3-4 Trials
8 emp Phase 3 Trials Results Used in
NDA Submission
10 emp Phase 2-4 Trials
GSK and GSK Biologicals
42 emp Phase 2-4 Trials
20 emp 28 Bed Phase 1
Unit Phase 3-4 Trials
12 emp Phase 2-3 Trials Centralized Data
32 emp Phase 2-4 Trials
65 emp 31 bed Phase 1
Unit Japan Bridging
Studies
6 emp Phase 2-3 Trials Results Used in
NDA Submission
4 emp Phase 2-4 Trials Data Management
22 emp Phase 2-4 Trials Data Management
LILLY
Bristol-Myers Squibb Company
Local: Early Phase and Complex TrialsLocal: Early Phase and Complex Trials
History | KBE | Biomed | S&E | Talent | Enterprise
Fusion of Science and Engineering
History | KBE | Biomed | S&E | Talent | Enterprise
Science & Engineering Industry Clusters
ELECTRONICS INFOCOMM
ENGINEERINGCHEMICALS
Semiconductors
Storage & PeripheralsDevices
Digital Content & Media
Software & Computing
Communications
Petroleum/Petrochemicals
Performance Materials
Bio & Consumer Chemistry
Specialty Chemicals
Process Engineering *
Advanced Display
Electronic Components
Electronic Modules
Microelectronics
Computational Science
DataStorage
Infocomm Research
Chemical Sciences
Material Science & Engineering
Manufacturing Technology
I2RIME
DSI
IMRE
ICES
SIMTech
IHPC
Machinery & Systems
Precision Modules
Aerospace
Precision Components
Marine & Offshore
Automotive
Alignment of SERC RIs to meet Industry Needs
Science and Engineering Cluster Map
History | KBE | Biomed | S&E | Talent | Enterprise
ELECTRONICS INFOCOMM
ENGINEERINGCHEMICALS
Machinery & Systems
Precision Modules
Aerospace
Precision Components
Offshore Engrg
Petroleum/Petrochemicals
Performance Materials
Bio & Consumer Chemistry
Specialty Chemicals
Process Engineering
MicroElectronics
DataStorage
Info-Comm Sciences
Chemical Sciences
Materials Sciences
Manufacturing Technology
Devices
Digital Content & Media
Software & Computing
Communications
Semiconductors
Storage & Peripherals
Advanced Display
Electronic Components
Electronic Modules
Home 2015
Ultra wide BandPolymer Elec.
Photonics
Nano-elect.
Sensors
Mfg Systems
Imaging
Human-factor Engineering
Energy
SyntheticChemistry
Nanotechnology
Human-machine interface
Arrayed sensor networks
Developing New Competencies
History | KBE | Biomed | S&E | Talent | Enterprise
SERC Research Institutes
Data Storage Institute (DSI)
Institute for Chemical & Engineering
Sciences (ICES)
Institute for Infocomm Research (I2R)
Institute of Micro-
electronics (IME)
Institute of Materials Research & Engineering (IMRE)
Institute of High Performance Computing (IHPC)
Singapore Institute of Manufacturing Technology (SIMTech)
History | KBE | Biomed | S&E | Talent | Enterprise
SERC RIs initiated
838 Industry R&D projects from FY01-FY06*
* As of 31st December 2006
Attracting and Anchoring Corporate R&D activities
History | KBE | Biomed | S&E | Talent | Enterprise
Fusionopolis – Home for Integration of Technologies and Capabilities
Devices
(IME, DSI)
Materials (IMRE)
ComputerModeling (IHPC)
Platform (SIMTech / IME)Technologies
Systems / Applications (I2R)
Sy
ste
m In
teg
rati
on
(SIM
Te
ch)
Central Facilities
Chemistry (ICES)
History | KBE | Biomed | S&E | Talent | Enterprise
SERC, CPAD, ETPL, I2R, IHPC, DSI (network storage), SIMTech (Industrial
Informatics) located at Fusionopolis Phase 1
Fusionopolis Phase 1 Facilities
History | KBE | Biomed | S&E | Talent | Enterprise
Singapore’s most powerful Computers- driving innovations
S'pore's largest R&D cleanroom at your service
State-of-the-art cleanroom
Small Matters!produce high-resolution,
3D images down
to an atomic level
Science meets businessPartnering industry in joint
development of next
generation technologies
Integration of SERC RI Capabilities
Bringing TechnologyFrom the labs to
Your Daily Experienceexperimental place to innovate
and create ideas
for R&D and new applications
A Magnet for the Best and Brightest
Outstanding researchers with diverse cultures to create highly inventive environment
Area of Phase 1 : 120,000m2Area of Phase 2 : 103,688m2No. of Researchers : > 1600
Realising Fusionopolis
One-North
FUSIONpolis – Aerial view
Circle line MRT
Co-location of Fusionopolis and Biopolis
History | KBE | Biomed | S&E | Talent | Enterprise
HUMAN CAPITAL
make up a Knowledge-Based Economy (KBE)
History | KBE | Biomed | S&E | Talent | Enterprise
Human Capital - Whales
History | KBE | Biomed | S&E | Talent | Enterprise
2001
Dr Edison Liu Executive Director,
GIS
2002
Dr Yoshiaki Ito PI, IMCB
2003 2004 2005 2006
Sir David Lane Executive Director, IMCB & Executive
Dy Chmn (BSTG), BMRC
Dr Birgitte Lane Executive
Director, IMB
Dr Neal Copeland & Dr Nancy Jenkins
PIs, IMCB
Dr Phil InghamPI, IMCB
Dr Jean Paul Thiery
PI, IMCB
Dr Edward HolmesExecutive Dy Chmn (TCSG), BMRC &
Chmn, NMRC
Dr Judith Swain
Executive Director, SICS
Dr Philippe Kourilsky Chairman, SIgN
Dr Axel Ullrich Director, SOG Lab
Sir George Radda Chairman, SBIC
Dr Jackie YingExecutive
Director, IBN
When physician-scientists Judith Swain and Ed Holmes take up their posts in Singapore…, they will join a star-studded community at one of the world’s most rapidly developing biomedical research centres. …they are the latest of many Western scientists who have headed for the impressive facilities of the tiny city-state.
Naturejobs, 5 Jul 06
Attracting International Talent (Whales)
History | KBE | Biomed | S&E | Talent | Enterprise
Human Capital - Guppies
History | KBE | Biomed | S&E | Talent | Enterprise
YouthScience
YRAP & JC Awards
NSS(BS)NSS(PhD)
AGSIF(MD)
10-14 yrs < 35 yrs
Nurturing & Developing Human Capital (Guppies)
15-18 yrs 19-23 yrs 24-30 yrs
Talent Pipeline
History | KBE | Biomed | S&E | Talent | Enterprise
Gu
pp
ies
Sen
ior
Gu
pp
ies
Yo
un
gW
hal
es
A*STAR SCHOLARSHIPS
BS
International Fellowship (IF) for Medical Doctors
PhD
National Science Scholarships
(NSS)
A*STAR Graduate Scholarships
(AGS)
Imperial College London, UK
National University of Singapore
University of Illinois, Urbana-Champaign, USA
Karolinska Institutet, Sweden
University of Dundee, UK
Nanyang Technological University
Carnegie Mellon University, USA
Nurturing & Developing Human Capital
University of Cambridge, UK
MBBS-PhD
History | KBE | Biomed | S&E | Talent | Enterprise
(3 years)
(3-5 years)
(8 years)
(1-2 years)
MITPhysics
(Malaysia)
Human Capital: International Guppies
StanfordChemical Engineering
(Shanghai)
MITBio Engineering
(Hong Kong)
MITChemical Engineering
(Germany)
StanfordComputer Science
(India)
MITChemical Engineering
(Vietnam)
RockefellerBacteriology
Human Capital: Singapore Guppies
StanfordBiochemistry
StanfordBiochemistry
Medicine/PhDDuke
Medicine/PhDCamrbidge, London
Computer ScienceCarnegie-Mellon
International Linkages
History | KBE | Biomed | S&E | Talent | Enterprise
A*STAR Partners in PhD TrainingA*STAR Partners in PhD Training
• PhD studies in Biomedical Sciences, Physical Sciences and Engineering
• Scholars are supervised throughout their course of study• Upon completion, Scholar is awarded PhD degree from the
respective university• Promotes collaborations between A*STAR Research Institutes &
Universities
LOCAL
OVERSEAS
History | KBE | Biomed | S&E | Talent | Enterprise
NSS(BS) - 3 yrs
232*AGS - 4 yrs
217 at partner universities
NSS(PhD) - 4-5 yrs
200overseas
46 Completed PhDs
Nurturing & Developing Human Capital695 Potential and Completed PhDs
IF
Correct as at 25 July 2007•Of which, 70 BS and 1 MBBS are NSFs.
755
Completed
History | KBE | Biomed | S&E | Talent | Enterprise
Ng San San,
Susanne
Yar Kar Peo
KeefeChng
Ho Ying Swan
WongEeTsin
Yeo Yong Kee
Zhang Rui
Completed PhDsCompleted PhDs
ChowKeat
Theng
Andrea Pillai
Amanda Chan
CleoChoong
Chit Fang
Cheok
AnweshaDey
AndrewWan
Loo Li
Shen
Ang Hwee Ching
Andrew Ang
Gary Ng
Sum Huan
Leong Li
Ming
Yeo Sze Ling
Leong Siang Huei
Ng Kee Woei
Yuen Chau
Tng Hui Ching, Emilia
Foo Yong Lim
Ho HanKiat
Koh Kian Peng
LimChinYan
Low Yen Ling
Ng Sean Pin
Ng Ching Ging
Chua YangChoo
ChanKok
Ping
Teo Hsiang
Ling
TracyHo
Max Fun
Quek Su Ying
Wee Boon Yu
BiomedicalSciences
(30)
Science &Engineering
(16)
As of July 07
ChawKwanChun
Even More to Return with PhDsEven More to Return with PhDs
• 33 Completed PhDs returned in 2005-06.• 59 projected to return in 2007, of which 13 have already been deployed.• 80 projected to return annually on average from 2011.
Correct as at 1 August 2007Based on reaching annual scholarship targets up to 2010, and 10% attrition rate of NSS(BS) moving onto to PhD
Projected No. of Returning PhD Scholars
11
22
5965
3542
89
107
125120
135
82
55 54 54
27 27
0
20
40
60
80
100
120
140
160
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
LOCAL ENTERPRISE
DEVELOPMENT
R&D
Intellectual Property
Sustainable Vibrant
EconomyHistory | KBE | Biomed | S&E | Talent | Enterprise
Small & Medium Enterprises (SMEs) • 46% of GDP and 63% of employment
• Local SMEs: 25% of GDP and 51% of employment
• Small is NOT Beautiful. Few small enterprises survive in the long term
• Elephants can Dance
• Challenges:
How to sustain broad-based economic growth? How to encourage Innovation and Creativity?
History | KBE | Biomed | S&E | Talent | Enterprise
Contribution of Local SMEs (2005)
5
3.8
8.9
0
2
4
6
8
10
Manufacturing (Local SMEs)
percent
Note: SMEs are defined as enterprises with 30% or more local equity ownership, with net fixed assets investment of $15mil or less for manufacturing industries, and enterprises with 200 or less employees for service industries.
• Share of Enterprises • Contribution to GDP • Contribution to Employment
Local SMEs
90.8%
25.4%
51.0%
Foreign SMEs
8.6%
20.5%
11.5%
All SMEs
99.4%
45.9%
62.5%
Enterprises
Value Added
Employment75.1
19
34.8
0
20
40
60
80
Services (Local SMEs)
percent percent10.7
2.6
7.3
0
2
4
6
8
10
12
Others (Local SMEs)
History | KBE | Biomed | S&E | Talent | Enterprise
Number of Local Enterprises in Manufacturing & Services Sectors
Industry-led:
LEAD Prog
with industry associations
Source: EDB & DOS; excluded NPOs
Notes: ^ Figures are SPRING’s estimates
+ This group of enterprises meet the SMEs’ definitions and are eligible for SME incentives
* Excludes local SMEs in Construction, Utilities, Agriculture and Fishing (approx. 15,600 in 2005)
48,526
91^
48,435
163^
412^
575
824^
5,125^
5,949
41,911
SPRING’s Verticals
119,70141,289112,5177,1467,184Sub-total (<$50m):
55279^4648488 $25m - <$50m
1,562143^1,281269281 $10m - <$25m
46826^4006568 $50m & aboveLarge+
2,1142221,745353369$10m - <$50m
Medium
41,315
392^
3,346^
3,738
37,329
SPRING’s Verticals
112,917
2,001
12,765
14,766
96,006
All Ind.
Local Services SMEs (2004)
120,169
2,438
14,554
16,992
100,595
All Ind*.
TotalLocal Manufacturing SMEs (2005)
Sales RevenueSize of
Enterprises
7,252
437
1,789
2,226
4,589
All Ind.
2,211 $1m - <$10m
7,211Total:
432 $5m - <$10m
1,779 $1m - <$5mSmall
4,582 < $1mMicro
SPRING’s Verticals
Broad-based:
EnterpriseOne
with chambers
& major associations
Focused Support for
Growth Enterprises
~ 100,000 micro-sized enterprises; 20,000 Small & Medium-Sized Enterprises
“EVERY GREAT OAK TREE STARTED AS A DETERMINED ACORN”
Oak Trees
Acorn
TO HAVE A FOREST OF OAK TREES, WE
NEED TO SEED MANY (SURVIVING) ACORNS!
History | KBE | Biomed | S&E | Talent | Enterprise
Young ACORNs – “New Enterprises,
Start-ups”
Nurturing, Grooming –
“Work of economic agencies”
Oak Trees – “Future economic prosperity”
“Economic Decline”
History | KBE | Biomed | S&E | Talent | Enterprise
LIFE
DEATH
BIRTH
An acorn that does not grow up is a dead acorn !
The Economy is a dynamic Pyramid
Global Enterprises
Large Enterprises(output > $50 million)
Medium Enterprises (output < $50 million)
Small Enterprises (includes young start-ups)
History | KBE | Biomed | S&E | Talent | Enterprise
What Small and Medium Enterprises (SMEs) need ?
Know How/What
Management
Global Enterprises
Large Enterprises(output > $50 million)
Medium Enterprises (output < $50 million)
Small Enterprises (includes young start-ups)
Money
Markets
History | KBE | Biomed | S&E | Talent | Enterprise
Management
Partner MAS and Financial Institutions
to enhance SMEs’ access to financing
Money
Partner IE and EDB to increase
overseas market access
Markets
Know-how / Know-what
Partner Universities to upgrade management competence
Partner A*STAR, Universities and Polytechnics to help companies acquire & adopt technologies to
innovate and grow
The 3MK Strategy
History | KBE | Biomed | S&E | Talent | Enterprise
Guiding principles1) Private sector is primary source of funds2) Government plays catalytic role where there are gaps3) Involve private sector partners
Enhance SME Financing
Review Regulations
Educate and
Raise Awareness
Provide Complementary
Sources of Financing
$ $ $ for SMEs
Improve Access to Overseas Markets
Facilitate access to Global marketsFacilitate access to Global markets
Link SMEs to MNCs and foreign SMEsLink SMEs to MNCs and foreign SMEs
Provide Export Technical Assistance Provide Export Technical Assistance History | KBE | Biomed | S&E | Talent | Enterprise
Enhancing Know-how / Know-what
• Research Institutes• Universities• Polytechnics• Technology service providers
SMEs
• Catalyze projects• Promote awareness• Partial funding
SPRING
•IES•EDB
Technology Innovation Programme (August 2007) $150m over 5 years to help local SMEs compete on technology, not just cost.
SMEs can tap on knowledge centres to innovate
• Individual companies• Consortia• Industry
Knowledge Centres
History | KBE | Biomed | S&E | Talent | Enterprise
A*STAR
Upgrade Management Skills
• Co-fund and train 1,000 SME CEOs and Managers over 5 years
• Funded local Universities to develop curriculum for
SMEs
• EMBA and Executive Development courses
History | KBE | Biomed | S&E | Talent | Enterprise
Management Development Programme (April 2007)
3G – Grow, Glow and Globalise
Global Enterprises
Large Enterprises(output > $50 million)
Medium Enterprises (output < $50 million)
Small Enterprises (includes young start-ups)
SPRING
- Enterprise development
A*STAR
- Generating Know How
- Attracting Whales (Talent)
EDB
- Attracting Overseas Investments
IE Singapore
- Oversee Markets Access
History | KBE | Biomed | S&E | Talent | Enterprise
Key Challenges for Singapore
• Face Global Competition
History | KBE | Biomed | S&E | Talent | Enterprise
• Transit from Manufacturing to “know-how”, a Knowledge Based Economy (KBE)
• Nurture an Enterprise culture: - Passion (risk taking)- Determination (hard work)- Vision (Global)- Focus (Operational)